Severe ovarian hyperstimulation syndrome following gonadotropin releasing hormone agonist trigger and freeze all approach in GnRH antagonist protocol

Monday, March 31, 2014
Two case reports are presented, in which GnRH triggering and the freeze-all approach in a GnRH antagonist protocol resulted in the development of severe OHSS, requiring hospitalization and peritoneal drainage.

Read More

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth an analysis of 256381 in vitro fertilization cycles

Monday, March 31, 2014
The retrieval of >15 oocytes in fresh autologous IVF cycles significantly increases the risk of ovarian hyperstimulation syndrome without improving live-birth rate.

Read More

Cabergoline for the prevention of ovarian hyperstimulation syndrome systematic review and meta analysis of randomized controlled trials

Thursday, February 20, 2014
Cabergoline reduces the occurrence of moderate-severe ovarian hyperstimulation syndrome and probably does not have a clinically relevant impact on clinical pregnancy or on the number of retrieved oocytes.

Read More

Reference range for the antimullerian hormone Generation II assay A population study of 10984 women with comparison to the established Diagnostics Systems Laboratory nomogram

Friday, January 31, 2014
Antimüllerian hormone (AMH) exhibits an age-related decline, but the population distribution suggests that the current AMH Generation II assay standardization is not as reported by the manufacturer.

Read More

Measurement of antimüllerian hormone not as straightforward as it seems

Friday, January 31, 2014
Reflections on "Reference range for the antimüllerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram" by Nelson et al.

Read More

In vitro maturation A committee opinion

Friday, March 1, 2013
In vitro maturation should be performed only as an experimental procedure for carefully selected patients evaluating both efficacy and safety.

Read More

Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women

Monday, June 18, 2012
While AFC and age are predictive of live birth following IVF treatment, AFC demonstrates a stronger positive correlation. This study illustrates post-test probabilities of live birth at individual AFC thresholds.

Read More

A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist

Monday, June 4, 2012
Treatment with gonadotropin-releasing hormone antagonist improved the clinical, laboratory and ultrasonographic parameters of a pituitary adenoma secreting follicle-stimulating hormone associated with ovarian hyperstimulation which persisted after transsphenoidal surgery.

Read More

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles

Friday, June 1, 2012
The incidence of first-trimester venous thromboembolism in IVF pregnancies was 0.2%, which was mainly attributed to a 100-fold increased risk in cycles complicated by ovarian hyperstimulation syndrome.

Read More

Translate »